Encoded Therapeutics Inc. logo

Encoded Therapeutics Inc. Funding & Investors

Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad range of severe genetic disorders. The company's therapy pipeline addresses devastating genetic and acquired disorders spanning multiple disease pathways including neurocircuitry, metabolic disorders, neurodegeneration and cardiovascular disease, enabling medical practitioners to treat patients and improve their lives.

encoded.com

Total Amount Raised: $239,100,000

Encoded Therapeutics Inc. Funding Rounds

  • Series D

    $135,000,000

    Series D Investors

    GV
    Boxer Capital
    RTW Investments
    Illumina Ventures
    Meritech Capital Partners
    Nolan Capital
    Farallon Capital Management
    Menlo Ventures
    Arch Venture Partners
    SoftBank Vision Fund
    Matrix Capital Management
    Green Sands Equity
  • Series C

    $104,000,000

    Series C Investors

    Arch Venture Partners
    Venrock
    Alexandria Venture Investments
    RTW Investments
    Illumina Ventures
    Menlo Ventures
    Boxer Capital
    Matrix Capital Management
    Altitude Life Science Ventures
  • Convertible Note

    $100,000

    Convertible Note Investors

    Illumina
Funding info provided by Diffbot.